Presence of Some Commonly used Pharmaceutical Residues in Seawater and Net Plankton: a Case Study of Spitsbergen, Svalbard Archipelago

Year 2022, Volume: 9 Issue: 4, 1 - 10, 25.12.2022

Nagihan Ersoy Korkmaz , Abdullah Aksu , Burak Karacık , İrşad Bayırhan , Nuray Çağlar , Cem Gazioğlu , Burcu Özsoy

https://doi.org/10.30897/ijegeo.1057819

Cited By: 2

Abstract

The occurrence of eleven pharmaceutical compounds in the surface seawater and plankton samples from Spitsbergen, Svalbard Archipelago, were investigated. The target compounds included diclofenac, fenoprofen, ketoprofen, ibuprofen, naproxen, carbamazepine, clofibric acid, gemfibrozil, estrone, 17β-estradiol, and 17α-ethynylestradiol, which are among the most widely used pharmaceuticals in the world. The water samples were extracted by liquid-liquid extractions, which were followed by solid-phase extractions (SPE). Ultrasonic extractions were used for the plankton samples, and a clean-up process was then carried out using the SPE method. The quantifications of the pharmaceutical compounds were obtained by using high-performance liquid chromatography (HPLC–DAD). The highest concentrations (2.17 µg L-1) that were measured in seawater were for gemfibrozil. 17α-ethynylestradiol and fenoprofen were the most abundant pharmaceuticals that were detected in the seawater samples. All of the studied compounds were detected in the plankton samples. The concentrations of ibuprofen (4543 ng g-1), 17β-estradiol (3338 ng g-1), 17α-ethynylestradiol (3262 ng g-1), and gemfibrozil (6940 ng g-1) were high in the plankton samples. Pharmaceutical compounds have been identified in the Arctic region due to the inadequate or incomplete wastewater treatment facilities in this region, which exhibit reduced biodegradation levels at low temperatures and prolonged half-life for the compounds in the receiving environments at low temperatures.

Keywords

pharmaceutical residues;, seawater, plankton, Arctic

Supporting Institution

Istanbul Technical University Polar Research Center; Isbank

Thanks

The authors would like to thank the Istanbul Technical University Polar Research Center for coordinating the expedition, Isbank for sponsoring the expedition, all scientists for their contributions, and, last but not least, the crew of Anakena for helping the expedition to be a success.

References

• Adeel, M., Song, X., Wang, Y., Francis, D., & Yang, Y. (2017). Environmental impact of estrogens on human, animal and plant life: A critical review. Environment International, 99, 107-119.
• Almeida, Â., Solé, M., Soares, A.M.V.M., & Freitas, R. (2020). Anti-inflammatory drugs in the marine environment: Bioconcentration, metabolism and sub-lethal effects in marine bivalves. Environmental Pollution, 263, 114442.
• Álvarez-Muñoz, D., Rodríguez-Mozaz, S., Maulvault, A. L., Tediosi, A., Fernández-Tejedor, M., Van den Heuvel, F., Kotterman, M., Marques, A., Barceló, D. (2015). Occurrence of pharmaceuticals and endocrine disrupting compounds in macroalgaes, bivalves, and fish from coastal areas in Europe. Environ Res, 143(Pt B), 56-64.
• Alygizakis, N.A., Gago-Ferrero, P., Borova, V.L., Pavlidou, A., Hatzianestis, I., & Thomaidis, N.S. (2016). Occurrence and spatial distribution of 158 pharmaceuticals, drugs of abuse and related metabolites in offshore seawater. Science of The Total Environment, 541, 1097-1105.
• Andreozzi, R., Raffaele, M., & Nicklas, P. (2003). Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere, 50(10), 1319-1330. Anekwe, J., Abou-Elwafa Abdallah, M., & Harrad, S. (2017). Pharmaceuticals and personal care products (PPCPs) in the freshwater aquatic environment. Emerging Contaminants, 3(1), 1-6.
• Araujo, L., Villa, N., Camargo, N., Bustos, M., García, T., & Prieto, A. d. J. (2011). Persistence of gemfibrozil, naproxen and mefenamic acid in natural waters. Environmental Chemistry Letters, 9(1), 13-18.
• Archer, E., Petrie, B., Kasprzyk-Hordern, B., & Wolfaardt, G.M. (2017). The fate of pharmaceuticals and personal care products (PPCPs), endocrine disrupting contaminants (EDCs), metabolites and illicit drugs in a WWTW and environmental waters. Chemosphere, 174, 437-446.
• Arpin-Pont, L., Bueno, M.J., Gomez, E., & Fenet, H. (2016). Occurrence of PPCPs in the marine environment: a review. Environ Sci Pollut Res Int, 23(6), 4978-4991. Aydin, E., & Talinli, I. (2013). Analysis, occurrence and fate of commonly used pharmaceuticals and hormones in the Buyukcekmece Watershed, Turkey. Chemosphere, 90(6), 2004-2012.
• Baena-Nogueras, R.M., González-Mazo, E., & Lara-Martín, P.A. (2017). Degradation kinetics of pharmaceuticals and personal care products in surface waters: photolysis vs biodegradation. Science of The Total Environment, 590-591, 643-654.
• Benotti, M.J., & Brownawell, B.J. (2009). Microbial degradation of pharmaceuticals in estuarine and coastal seawater. Environmental Pollution, 157(3), 994-1002. Bianchi, T.S., Arndt, S., Austin, W.E.N., Benn, D.I., Bertrand, S., Cui, X., Faust, J.C., Koziorowska-Makuch, K., Moy, C.M., Savage, C., Smeaton, C., Smith, R.W., Syvitski, J. (2020). Fjords as Aquatic Critical Zones (ACZs). Earth-Science Reviews, 203, 103145.
• Błaszczyk, M., Ignatiuk, D., Uszczyk, A., Cielecka-Nowak, K., Grabiec, M., Jania, J., Moskalik, M., Walczowski, W. (2019). Freshwater input to the Arctic fjord Hornsund (Svalbard). Polar Research, 38.
• Bogen, J., & Bønsnes, T.E. (2003). Erosion and sediment transport in High Arctic rivers, Svalbard. Polar Research, 22(2), 175-189.
• Brausch, J.M., Connors, K.A., Brooks, B.W., & Rand, G.M. (2012). Human pharmaceuticals in the aquatic environment: a review of recent toxicological studies and considerations for toxicity testing. Rev Environ Contam Toxicol, 218, 1-99.
• Brausch, J. M., & Rand, G. M. (2011). A review of personal care products in the aquatic environment: environmental concentrations and toxicity. Chemosphere, 82(11), 1518-1532.
• Bueno, M.J.M., Gomez, M.J., Herrera, S., Hernando, M. D., Agüera, A., & Fernández-Alba, A.R. (2012). Occurrence and persistence of organic emerging contaminants and priority pollutants in five sewage treatment plants of Spain: Two years pilot survey monitoring. Environmental Pollution, 164, 267-273.
• Buser, H.-R., Poiger, T., & Müller, M.D. (1999). Occurrence and Environmental Behavior of the Chiral Pharmaceutical Drug Ibuprofen in Surface Waters and in Wastewater. Environmental Science & Technology, 33(15), 2529-2535.
• Butt, C.M., Berger, U., Bossi, R., & Tomy, G.T. (2010). Levels and trends of poly- and perfluorinated compounds in the arctic environment. Science of the Total Environment, 408(15), 2936-2965.
• Camacho-Muñoz, D., Martín, J., Santos, J.L., Aparicio, I., & Alonso, E. (2009). An affordable method for the simultaneous determination of the most studied pharmaceutical compounds as wastewater and surface water pollutants. J Sep Sci, 32(18), 3064-3073.
• Choi, Y., Kim, K., Kim, D., Moon, H.-B., & Jeon, J. (2020). Ny-Ålesund-oriented organic pollutants in sewage effluent and receiving seawater in the Arctic region of Kongsfjorden. Environmental Pollution, 258, 113792.
• Claessens, M., Vanhaecke, L., Wille, K., & Janssen, C. R. (2013). Emerging contaminants in Belgian marine waters: Single toxicant and mixture risks of pharmaceuticals. Marine Pollution Bulletin, 71(1), 41-50.
• Clara, M., Strenn, B., & Kreuzinger, N. (2004). Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration. Water Research, 38(4), 947-954.
• Çetin, O., & Büyüksağnak, Y. B. (2021). Turkey's interest in the Arctic region: the evaluation of being a party to the Svalbard Treaty. International Journal of Environment and Geoinformatics, 8(3), 350-358.
• Daneshvar, A., Svanfelt, J., Kronberg, L., Prévost, M., & Weyhenmeyer, G.A. (2010). Seasonal variations in the occurrence and fate of basic and neutral pharmaceuticals in a Swedish river–lake system. Chemosphere, 80(3), 301-309.
• Debska, J., Kot-Wasik, A., & Namiesnik, J. (2005). Determination of nonsteroidal antiinflammatory drugs in water samples using liquid chromatography coupled with diode-array detector and mass spectrometry. J Sep Sci, 28(17), 2419-2426.
• Del Rosario, K.L., Mitra, S., Humphrey, C.P.,Jr., & O'Driscoll, M.A. (2014). Detection of pharmaceuticals and other personal care products in groundwater beneath and adjacent to onsite wastewater treatment systems in a coastal plain shallow aquifer. Science of the Total Environment, 487, 216-223.
• Ebele, A.J., Abou-Elwafa Abdallah, M., & Harrad, S. (2017). Pharmaceuticals and personal care products (PPCPs) in the freshwater aquatic environment. Emerging Contaminants, 3(1), 1-16.
• Emídio, E.S., Calisto, V., de Marchi, M.R.R., & Esteves, V.I. (2017). Photochemical transformation of zearalenone in aqueous solutions under simulated solar irradiation: Kinetics and influence of water constituents. Chemosphere, 169, 146-154.
• Fang, T.-H., Lin, C.-W., & Kao, C.-H. (2019). Occurrence and distribution of pharmaceutical compounds in the Danshuei River Estuary and the Northern Taiwan Strait. Marine Pollution Bulletin, 146, 509-520.
• Fein, J. B. (2002). The effects of ternary surface complexes on the adsorption of metal cations and organic acids onto mineral surfaces. In: Hellmann, R., Wood S.A. (Eds.), Water-Rock Interactions, Ore Deposits, and Environmental Geochemistry A tribute to David A. Crerar (pp. 365-378). Washington, ABD: The Geochemical Society, Special Publication No 7.
• Fent, K., Weston, A.A., & Caminada, D. (2006). Ecotoxicology of human pharmaceuticals. Aquatic Toxicology, 76(2), 122-159.
• Forwick, M., Vorren, T., Hald, M., Korsun, S., Roh, Y., Vogt, C., & Yoo, K.-C. (2010). Spatial and temporal influence of glaciers and rivers on the sedimentary environment in Sassenfjorden and Tempelfjorden, Spitsbergen. Geological Society of London Special Publications, 344, 163-193.
• Gaw, S., Thomas, K.V., & Hutchinson, T.H. (2014). Sources, impacts and trends of pharmaceuticals in the marine and coastal environment. Philos Trans R Soc Lond B Biol Sci, 369(1656), 20130572.
• Green, N., Schlabach, M., Bakke, T., Brevik, E., Dye, C., Herzke, D., Huber, S., Plosz, B., Remberger, M., Schøyen, M., Uggerud, H., Vogelsang, C. (2008). Screening of Selected Metals and New Organic Contaminants 2007. Norway: Norwegian Institute for Water Research.
• Gunnarsdóttir, R., Jenssen, P. D., Erland Jensen, P., Villumsen, A., & Kallenborn, R. (2013). A review of wastewater handling in the Arctic with special reference to pharmaceuticals and personal care products (PPCPs) and microbial pollution. Ecological Engineering, 50, 76-85.
• Huber, S., Remberger, M., Götsch, A., Davanger, K., Kaj, L., Herzke, D., Schlabach, M., Jörundsdóttir, H., Vester, J., Arnórsson, M., Mortensen, I., Schwartson, R., Dam, M. (2013). Pharmaceuticals and personal care products as environmental pollutants in Faroe Islands, Iceland and Greenland. Denmark: TemaNord 2013:541.
• Jin, X., Xu, H., Qiu, S., Jia, M., Wang, F., Zhang, A., & Jiang, X. (2017). Direct photolysis of oxytetracycline: Influence of initial concentration, pH and temperature. Journal of Photochemistry and Photobiology A: Chemistry, 332, 224-231.
• Johansen, S., Poste, A., Allan, I., Evenset, A., & Carlsson, P. (2021). Terrestrial inputs govern spatial distribution of polychlorinated biphenyls (PCBs) and hexachlorobenzene (HCB) in an Arctic fjord system (Isfjorden, Svalbard). Environmental Pollution, 281, 116963.
• Kallenborn, R., Brorström-Lundén, E., Reiersen, L.-O., & Wilson, S. (2018). Pharmaceuticals and personal care products (PPCPs) in Arctic environments: indicator contaminants for assessing local and remote anthropogenic sources in a pristine ecosystem in change. Environmental Science and Pollution Research, 25(33), 33001-33013.
• Kallenborn, R., Fick, J., Lindberg, R., Moe, M., Nielsen, K., Tysklind, M., & Vasskog, T. (2008). Pharmaceutical Residues in Northern European Environments: Consequences and Perspectives. In: Kümmerer, K. (Ed.), Pharmaceuticals in the Environment (pp. 61-74), London: Springer.
• Kim, I., & Tanaka, H. (2009). Photodegradation characteristics of PPCPs in water with UV treatment. Environment International, 35(5), 793-802.
• Koumaki, E., Mamais, D., Noutsopoulos, C., Nika, M.-C., Bletsou, A.A., Thomaidis, N.S., Eftaxias, A., Stratogianni, G. (2015). Degradation of emerging contaminants from water under natural sunlight: The effect of season, pH, humic acids and nitrate and identification of photodegradation by-products. Chemosphere, 138, 675-681.
• Kramer, R.D., Filippe, T.C., Prado, M.R., & de Azevedo, J.C.R. (2018). The influence of solid-liquid coefficient in the fate of pharmaceuticals and personal care products in aerobic wastewater treatment. Environ Sci Pollut Res Int, 25(25), 25515-25525.
• Kümmerer, K. (2009). Antibiotics in the aquatic environment – A review – Part I. Chemosphere, 75(4), 417-434.
• Kwon, J.W., & Armbrust, K.L. (2008). Aqueous solubility, n-octanol-water partition coefficient, and sorption of five selective serotonin reuptake inhibitors to sediments and soils. Bull Environ Contam Toxicol, 81(2), 128-135.
• Lam, M.W., Young, C.J., Brain, R.A., Johnson, D.J., Hanson, M.A., Wilson, C.J., Richards, S.M. Solomon, K.R. Mabury, S.A. (2004). Aquatic persistence of eight pharmaceuticals in a microcosm study. Environ Toxicol Chem, 23(6), 1431-1440.
• Liu, J.-L., & Wong, M.-H. (2013). Pharmaceuticals and personal care products (PPCPs): A review on environmental contamination in China. Environment International, 59, 208-224.
• Lonappan, L., Brar, S.K., Das, R.K., Verma, M., & Surampalli, R.Y. (2016). Diclofenac and its transformation products: Environmental occurrence and toxicity - A review. Environment International, 96, 127-138.
• Loraine, G.A., & Pettigrove, M.E. (2006). Seasonal Variations in Concentrations of Pharmaceuticals and Personal Care Products in Drinking Water and Reclaimed Wastewater in Southern California. Environmental Science & Technology, 40(3), 687-695.
• Mezzelani, M., Gorbi, S., & Regoli, F. (2018). Pharmaceuticals in the aquatic environments: Evidence of emerged threat and future challenges for marine organisms. Mar Environ Res, 140, 41-60.
• NCBI. (2020). National Center for Biotechnology Information. Retrieved 26 June 2020 from https://www.ncbi.nlm.nih.gov.
• Patel, A., Bell, M., O’Connor, C., Inchley, A., Wibawa, J., & Lane, M. E. (2013). Delivery of ibuprofen to the skin. International Journal of Pharmaceutics, 457(1), 9-13.
• Runnalls, T.J., Margiotta-Casaluci, L., Kugathas, S., &Sumpter, J.P. (2010). Pharmaceuticals in the Aquatic Environment: Steroids and Anti-Steroids as High Priorities for Research. Human and Ecological Risk Assessment: An International Journal, 16(6), 1318-1338.
• Scheytt, T., Mersmann, P., Lindstädt, R., & Heberer, T. (2005). Determination of sorption coefficients of pharmaceutically active substances carbamazepine, diclofenac, and ibuprofen, in sandy sediments. Chemosphere, 60(2), 245-253.
• Silva, B.F.d., Jelic, A., López-Serna, R., Mozeto, A.A., Petrovic, M., & Barceló, D. (2011). Occurrence and distribution of pharmaceuticals in surface water, suspended solids and sediments of the Ebro river basin, Spain. Chemosphere, 85(8), 1331-1339.
• Vasskog, T., Anderssen, T., Pedersen-Bjergaard, S., Kallenborn, R., & Jensen, E. (2008). Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway. J Chromatogr A, 1185(2), 194-205.
• Vasskog, T., Berger, U., Samuelsen, P. J., Kallenborn, R., & Jensen, E. (2006). Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway. J Chromatogr A, 1115(1-2), 187-195.
• Walczowski, W., & Piechura, J. (2006). New evidence of warming propagating toward the Arctic Ocean. Geophysical Research Letters, 33(12), 1-5.
• Wang, Z., Na, G., Ma, X., Ge, L., Lin, Z., & Yao, Z. (2015). Characterizing the distribution of selected PBDEs in soil, moss and reindeer dung at Ny-Ålesund of the Arctic. Chemosphere, 137, 9-13.
• Weigel, S., Berger, U., Jensen, E., Kallenborn, R., Thoresen, H., & Hühnerfuss, H. (2004). Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites. Chemosphere, 56(6), 583-592.
• Weigel, S., Kallenborn, R., & Hühnerfuss, H. (2004). Simultaneous solid-phase extraction of acidic, neutral and basic pharmaceuticals from aqueous samples at ambient (neutral) pH and their determination by gas chromatography–mass spectrometry. Journal of Chromatography A, 1023(2), 183-195.
• Westerhoff, P., Yoon, Y., Snyder, S., & Wert, E. (2005). Fate of Endocrine-Disruptor, Pharmaceutical, and Personal Care Product Chemicals during Simulated Drinking Water Treatment Processes. Environmental Science & Technology, 39(17), 6649-6663.
• Xie, H., Hao, H., Xu, N., Liang, X., Gao, D., Xu, Y., Liang, X., Gao, D., Xu, Y., Gao, Y., Tao, H., Wong, M. (2019). Pharmaceuticals and personal care products in water, sediments, aquatic organisms, and fish feeds in the Pearl River Delta: Occurrence, distribution, potential sources, and health risk assessment. Science of The Total Environment, 659, 230-239.
• Xuan, R., Blassengale, A. A., & Wang, Q. (2008). Degradation of Estrogenic Hormones in a Silt Loam Soil. Journal of Agricultural and Food Chemistry, 56(19), 9152-9158.
• Yamamoto, H., Nakamura, Y., Moriguchi, S., Nakamura, Y., Honda, Y., Tamura, I., Hirata, Y., Hayashi, A., Sekizawa, J. (2009). Persistence and partitioning of eight selected pharmaceuticals in the aquatic environment: Laboratory photolysis, biodegradation, and sorption experiments. Water Research, 43(2), 351-362.
• Zaborska, A., Strzelewicz, A., Rudnicka, P., & Moskalik, M. (2020). Processes driving heavy metal distribution in the seawater of an Arctic fjord (Hornsund, southern Spitsbergen). Mar Pollut Bull, 161(Pt A), 111719.
• Zhu, C., Li, Y., Wang, P., Chen, Z., Ren, D., Ssebugere, P., Zhang, Q., Jiang, G. (2015). Polychlorinated biphenyls (PCBs) and polybrominated biphenyl ethers (PBDEs) in environmental samples from Ny-Ålesund and London Island, Svalbard, the Arctic. Chemosphere, 126, 40-46.